Results


Robots Help Teach Social Skills to Kids with Autism Spectrum Disorder - News Center - The University of Texas at Dallas

#artificialintelligence

Now, a UT Dallas researcher is giving the fantasy of robotic friends a practical edge with a robot that teaches social skills to children with Autism Spectrum Disorder (ASD). "It's not to replace therapy with humans, but you can deliver a social skills lesson in a less threatening way, and the robot can deliver the same lesson multiple times," Rollins said. During a lesson, the robot explains a social situation to the child with ASD. Media Contact: Ben Porter, UT Dallas, (972) 883-2193, [email protected] or the Office of Media Relations, UT Dallas, (972) 883-2155, [email protected].


Robots Help Teach Social Skills to Kids with Autism Spectrum Disorder - News Center - The University of Texas at Dallas

#artificialintelligence

Now, a UT Dallas researcher is giving the fantasy of robotic friends a practical edge with a robot that teaches social skills to children with Autism Spectrum Disorder (ASD). "It's not to replace therapy with humans, but you can deliver a social skills lesson in a less threatening way, and the robot can deliver the same lesson multiple times," Rollins said. During a lesson, the robot explains a social situation to the child with ASD. Media Contact: Ben Porter, UT Dallas, (972) 883-2193, [email protected] or the Office of Media Relations, UT Dallas, (972) 883-2155, [email protected].


Diabetes Data Platform Leader Glooko Raises $35 Million in Series C

#artificialintelligence

The company will also increase commercialization efforts in France, Germany, the U.K., Asia and the Middle East, and further development efforts in data analytics and artificial intelligence to provide personalized insights that drive meaningful behavior change. Glooko provides payers, employers, pharmaceutical companies and health systems with a diabetes digital health platform that delivers personalized and actionable insights to people with diabetes and their care teams that aim to drive improved outcomes at a lower cost. "With this capital, we will accelerate our investments in clinical solutions that aim to increase medication adherence, provide personalized insights and prompts that drive behavior change for people with diabetes, and deliver clinical decision support to thousands of clinicians and coaches so they can better support people with diabetes in between office visits." Georgian Partners is a thesis-driven growth equity firm investing in SaaS-based business software companies exploiting applied artificial intelligence, security first and conversational business.


Leading Institutions to Focus on Improving Type 1 Diabetes Care with Machine Learning

#artificialintelligence

Children's Mercy is advancing care for children with diabetes through the Children's Mercy Diabetes Center by providing comprehensive care for children as well as support and resources for family members. About Joslin Diabetes Center Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Joslin is an independent, non-profit institution affiliated with Harvard Medical School, and one of only 11 NIH-designated Diabetes Research Centers in the U.S. About Cyft Based in Cambridge, Mass., Cyft partners with leading care organizations to identify opportunities to optimize care management efforts for chronic / complex, behavioral health, and dual-eligible populations. About the Helmsley Charitable Trust The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting effective organizations in health and select place-based initiatives.


Inova Translational Medicine Institute Partners with Cloudera to Advance Genome-Based Machine Learning Initiatives and Save Lives

#artificialintelligence

PALO ALTO, Calif., June 06, 2017 --Cloudera, Inc., (NYSE: CLDR), the leading provider of the modern platform for machine learning and advanced analytics built on the latest open source technologies, announced that Inova Translational Medicine Institute (ITMI), a global leading medical research institute, has deployed Cloudera Enterprise to securely analyze massive collections of clinical and genomic data at unprecedented speeds and scale for faster innovations in translational medicine research. As part of the Inova Center for Personalized Health (ICPH), ITMI's team of leading scientists, researchers, analysts and collaborators use machine learning algorithms on terabytes of clinical and genomic information to identify the genetic links to diseases. This genomic data analysis allows a bioinformatics scientist to study genomic correlations from people with conditions like arthritis, autoimmune diseases or cancer. Working with Cloudera, ITMI built a world-class bioinformatics infrastructure for the Institute's massively growing data collection of genomes paired against the clinical record.


42.cx - Center of Excellence for Artificial Intelligence AG: Artificial Intelligence to Fight Cardiovascular Disease

#artificialintelligence

Together with The Heart Fund, 42.cx wants to solve public health challenges by modelizing diseases patterns through applied artificial intelligence to support THF doctors during their medical tasks. The generated prediction system will run on portable devices to disrupt healthcare in developing countries and to fight cardiovascular disease. "The Heart Fund combats cardiovascular diseases by offering access to care to millions of children in developing countries. For the first time in history with this partnership, artificial intelligence scientists have access to thousands of electrocardiograms (ECG), blood panels, evaluations and resulting diagnosis.


Nvidia To Train 100,000 Developers In 'Deep Learning' AI To Bolster Healthcare Research

#artificialintelligence

Artificial Intelligence (AI) pioneer Nvidia has announced it will train 100,000 developers in "deep learning" to bolster health care research and improve treatment in diseases like cancer. In the past, cancer research institutes have looked into using Nvidia's latest advances in AI and deep learning to help pathologists with their overwhelming tasks. This is why Nvidia has revealed that it will train 100,000 developers this year through something it's calling the Deep Learning Institute (DLI); to provides developers, data scientists and researchers with practical training on the use of the latest AI tools and technology. The news comes after Nvidia released its first quarter earnings published on Tuesday, reporting quarterly revenue of $1.94 billion, up 48% year over year, and earning 79 cents per share, up 126% a year ago.


Artificial Intelligence Shows Potential to Fight Blindness - American Academy of Ophthalmology

#artificialintelligence

This advance has the potential to reduce the worldwide rate of vision loss due to diabetes. In a study published online in Ophthalmology, the journal of the American Academy of Ophthalmology, the researchers describe how they used deep-learning methods to create an automated algorithm to detect diabetic retinopathy. An ophthalmologist is a physician who specializes in the medical and surgical treatment of eye diseases and conditions. This is why an effective, automated algorithm could potentially reduce the rate of worldwide blindness.


5 UK tech firms using AI to transform healthcare

#artificialintelligence

DeepMind Health is leveraging machine learning technology – a form of AI – to boost the medical research field. Ali Parsa, Babylon's founder, told Tech City News that his app could potentially reduce expenditure by the NHS and improve system efficiency – cutting down the amount of time NHS call workers spend on the phone with patients calling its 111 line to discuss medical issues. Founded by Australian Neil Daly, the startup hopes to combat skin melanoma by allowing patients to track matters of concern via an AI-powered smartphone image recognition app. Antidote Match helps patients easily identify the trials that match to them; Connect Network streams the latest study information to patients on the platform; and Antidote Bridge enables users to add details about their studies.


Flipboard on Flipboard

#artificialintelligence

In its fourth quarter earnings release, the Santa Clara, Calif.-based company reported revenue of $2.17 billion, up 55% year over year, on earnings per share of $1.13, up 117% a year ago. "Deep learning on Nvidia GPUs [graphics processing units], a breakthrough approach to AI, is helping to tackle challenges such as self-driving cars, early cancer detection and weather prediction," said Nvidia cofounder and CEO Jen-Hsun Huang in a statement. The company's data center business appears safe for now. And its increasing faster over time: Last quarter, reported in November, Nvidia's data center business showed 193% growth in year-over-year revenue.